Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001628280-25-053417
Filing Date
2025-11-20
Accepted
2025-11-20 17:19:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2820
  Complete submission text file 0001628280-25-053417.txt   4597
Mailing Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035
Business Address 301 9-19 HACHIYAMA, SHIBUYA TOKYO M0 150-0035 81 90-3536-3820
Catalys Pacific Fund, LP (Reporting) CIK: 0001746274 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Subject) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-41614 | Film No.: 251503949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)